Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Yeh, Su-Peng
3075  Ergebnisse:
Personensuche X
?
1

Immune profiling of patients with extranodal natural killer..:

Qing, Min ; Zhou, Tianyuan ; Perova, Tatiana...
Annals of Hematology.  103 (2024)  6 - p. 1989-2001 , 2024
Link: https://doi.org/10.1007/..
 
?
2

The establishment of a multiple myeloma clinical registry i..:

Aoki, Naomi ; Chen, Pin-Yen ; Chen, Wenming...
BMC Medical Research Methodology.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Venetoclax Plus Azacitidine as a Bridge Treatment to Alloge..:

Chen, Tzu-Ting ; Lin, Ching-Chan ; Lo, Wen-Jyi...
Cancers.  16 (2024)  6 - p. 1082 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Treatment pattern among patients with relapsed/refractory m..:

Jerry Teng, Chieh-Lin ; Yeh, Su-Peng ; Chen, Tsai-Yun...
Hematology.  29 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
5

PB2130: MAGNETISMM-6: A PHASE 3 STUDY OF ELRANATAMAB + DARA..:

Grosicki, Sebastian ; Yeh, Su-Peng ; Huang, Shang-Yi...
HemaSphere.  7 (2023)  S3 - p. e039274c , 2023
Link: https://doi.org/10.1097/..
 
?
6

Clinical Features and Outcomes of Primary Breast Diffuse La..:

Teng, Ling-Chiao ; Liao, Yu-Min ; Gau, Jyh-Pyng...
Clinical Medicine Insights: Oncology.  17 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
7

Guadecitabine vs treatment choice in newly diagnosed acute ..:

Fenaux, Pierre ; Gobbi, Marco ; Kropf, Patricia L....
Blood Advances.  7 (2023)  17 - p. 5027-5037 , 2023
Link: https://doi.org/10.1182/..
 
?
8

POSTER: AML-469 Ivosidenib + Azacitidine vs Placebo + Azaci..:

de Botton, Stéphane ; Montesinos, Pau ; Polo, Susana Vives...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S166 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Case report: Sudden onset optic neuritis shortly after SARS..:

Chu, Chiang ; Jiang, Shin-Kuang ; Shao, Yi-Ching.
Frontiers in Medicine.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
10

P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RES..:

Döhner, Hartmut ; Montesinos, Pau ; Vives Polo, Susana...
HemaSphere.  7 (2023)  S3 - p. e83152da , 2023
Link: https://doi.org/10.1097/..
 
?
11

AML-469 Ivosidenib + Azacitidine vs Placebo + Azacitidine i..:

de Botton, Stéphane ; Montesinos, Pau ; Polo, Susana Vives...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S304 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Rates of Influenza and Pneumococcal Vaccination and Correla..:

Thompson, Michael A. ; Boccadoro, Mario ; Leleu, Xavier...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  3 - p. e171-e181 , 2023
Link: https://doi.org/10.1016/..
 
?
13

AML-295 AGILE: A Global, Randomized, Double-Blind, Phase 3 ..:

Dohner, Hartmut ; Montesinos, Pau ; Polo, Susana Vives...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S234 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Distinct Immunogenetic Profiles of Chronic Lymphocytic Leuk..:

Yao, Chi-Yuan ; Agathangelidis, Andreas ; Chuang, Shih-Sung...
HemaSphere.  6 (2022)  12 - p. e803 , 2022
Link: https://doi.org/10.1097/..
 
?
15

Poster: AML-295 AGILE: A Global, Randomized, Double-Blind, ..:

Dohner, Hartmut ; Montesinos, Pau ; Polo, Susana Vives...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S124 , 2022
Link: https://doi.org/10.1016/..
 
1-15